Spontaneous bacterial peritonitis: a therapeutic update

References

• Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J. Hepatol.18, 353–358 (1993).
   PubMed Web of Science ®Google Scholar
• Grange JD, Amiot X. Antibiotic prophylaxis of ascitic fluid infection. Gastroenterol. Clin. Biol.22, 301–304 (1998).
   PubMedGoogle Scholar
• Rimola A, Garcia-Tsao G, Navasa M et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J. Hepatol.32, 142–153 (2000).
   PubMed Web of Science ®Google Scholar
• Fernanadez J, Bauer TM, Navasa M, Rodés J. Diagnosis, treatment and prevention of spontaneous bacterial peritonitis. Ballieres Clin. Gastroenterol.14, 975–990 (2000).
   PubMed Web of Science ®Google Scholar
• Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology37, 897–890 (2003).
   PubMed Web of Science ®Google Scholar
• Titó L, Rimola A, Ginés P, Llach J, Arroyo V, Rodés J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology8, 27–31 (1988).
   PubMed Web of Science ®Google Scholar
• Kerr DNS, Pearson DT, Read AE. Infection of ascitic fluid in patients with hepatic cirrhosis. Gut4, 394–398 (1963).
   PubMed Web of Science ®Google Scholar
• Conn HO. Spontaneous peritonitis and bacteremia in Laennec’s cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome. Ann. Intern. Med.60, 568–580 (1964).
   PubMed Web of Science ®Google Scholar
• Toledo C, Salmerón JM, Rimola A et al. Spontaneous bacterial peritonitis in cirrosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology17, 251–257 (1993).
   PubMed Web of Science ®Google Scholar
• Rimola A, Bory F, Planas R, Xaubert A, Bruguera M, Rodés J. Infecciones bacterianas agudas em la cirrosis hepática. Gastroenterol. Hepatol.9, 453–459 (1981).
   Google Scholar
• Runyon BA, Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology4, 447–450 (1984).
   PubMed Web of Science ®Google Scholar
• Fernandez J, Navasa M, Gomez J et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology35, 140–148 (2002).
   PubMed Web of Science ®Google Scholar
• Singh N, Wagener MM, Gayowski T. Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplantation unit. Clin. Microbiol. Infect.9, 531–537 (2003).
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract. Res. Clin. Gastroenterol.18, 353–372 (2004).
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G. Milestones in liver disease. Spontaneous bacterial peritonitis: a historical perspective. J. Hepatol.41, 522–527 (2004).
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology108, 1835–1841 (1995).
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology120, 726–748 (2001).
   PubMed Web of Science ®Google Scholar
• Guarner C, Soriano G. Spontaneous bacterial peritonitis. Semin. Liver Dis. 17, 203–217 (1997).
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bartoli R, Planas R et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology23, 781–787 (1996).
   PubMed Web of Science ®Google Scholar
• Guarner C, Runyon BA, Young S, Heck M, Sheikl MY. Effect of long term trimethroprim–sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis and survival in cirrhotic rats. Dig. Dis. Sci.44, 1957–1962 (1999).
   PubMed Web of Science ®Google Scholar
• Cirera I, Bauer TM, Navasa M et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J. Hepatol.34(1), 150–155 (2001).
   PubMedGoogle Scholar
• Pérez-Paramo M, Muñoz J, Albillos A, Freile I, Portero F, Santos M. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology31, 43–48 (2000).
   PubMed Web of Science ®Google Scholar
• Guarner C, Runyon BA, Young S, Heck M, Sheih MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J. Hepatol.26, 1372–1378 (1997).
   PubMed Web of Science ®Google Scholar
• Chiva M, Guarner C, Peralta C et al. Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats. Eur. J. Gastroenterol. Hepatol.15, 145–150 (2003).
   PubMed Web of Science ®Google Scholar
• Navasa M, Rimola A, Rodés J. Bacterial infections in liver disease. Semin. Liver Dis.17(4), 323–333 (1997).
   PubMed Web of Science ®Google Scholar
• Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology8, 632–635 (1988).
   PubMed Web of Science ®Google Scholar
• Llach J, Rimola A, Navasa M et al. Incidence and predictive of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology16, 724–727 (1992).
   PubMed Web of Science ®Google Scholar
• Runyon BA. Low-protein concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology91, 1343–1346 (1986).
   PubMed Web of Science ®Google Scholar
• Guarner C, Sola R, Soriano G et al. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology117, 414–419 (1999).
   PubMed Web of Science ®Google Scholar
• Albillos A, de las Heras A, Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection. Lancet363, 1608–1610 (2004).
   PubMed Web of Science ®Google Scholar
• Frances R, Munoz C, Zapater P et al. Bacterial DNA activates cell-mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut53, 860–864 (2004).
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G. Portal hypertension. Curr. Opin. Gastroenterol.212, 313–322 (2005).
   Google Scholar
• Rimola A, Garcia-Tsao G, Navasa M et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J. Hepatol.32, 142–153 (2000).
   PubMed Web of Science ®Google Scholar
• Runyon BA. Management of adults patients with ascites due to cirrhosis. Hepatology39(3), 1–16 (2004).
   PubMedGoogle Scholar
• Deitch EA, Morrizon J, Berg RD. Effect of hemorrhagic schock on bacterial translocation, intestinal morphology and intestinal permeability in conventional and antibiotic-decontaminated rats. Crit. Care Med.18, 529–536 (1990).
   PubMed Web of Science ®Google Scholar
• Wong F, Bernardi M, Balk R et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut54, 718–725 (2005).
   PubMed Web of Science ®Google Scholar
• Brolin RE. Fulminant onset of spontaneous bacterial peritonitis. Dig. Dis. Sci.27, 364–366 (1982).
   PubMed Web of Science ®Google Scholar
• Runyon BA. Ascites and spontaneous bacterial peritonitis. In: Gastrointestinal and Liver Disease (Seventh Edition). Feldman M, Friedman LS, Sleisenger MH (Eds), Saunders, PA, USA, 1517–1542 (2002).
   Google Scholar
• Runyon BA, Hoefs JC. Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology4, 1209–1211 (1984).
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G. Spontaneous bacterial peritonitis. Hepatol. Rev.2, 108–112 (2004).
   Google Scholar
• Castellote J, López C, Gornals J et al. Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips. Hepatology37, 893–896 (2003).
   PubMed Web of Science ®Google Scholar
• Sapey T, Mandler MH, Kabissa D et al. Apport diagnostique des bandelettes urinaires (Nephur-Test et MultistixSG) dans l’infection spontanée du liquide d’ascite chez le cirrhotique (résumé). Gastroenterol. Clin. Biol.27, CO30 (2003).
   Google Scholar
• Vanbiervliet G, Rakotoarisoa C, Filippi J et al. Diagnostic accuracy of a rapid urine-screening test (Multistix 8 SG) in cirrhotic patients with spontaneous bacterial peritonitis. Eur. J. Gastroenterol. Hepatol.14, 1257–1260 (2002).
   PubMed Web of Science ®Google Scholar
• Sapey T, Kabissa D, Fort E, Laurin C, Mendler MH. Instant diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips: Nephur-Test vs. MultistixSG. Liver Int.25(3), 343–348 (2005).
   PubMed Web of Science ®Google Scholar
• Runyon BA. Strips and tubes: improving the diagnosis of spontaneous bacterial peritonitis. Hepatology37, 745–747 (2003).
   PubMed Web of Science ®Google Scholar
• Strauss E, Caly WR. Spontaneous bacterial peritonitis. Rev. Soc. Bras. Med. Trop.36(5), 711–717 (2003).
   PubMedGoogle Scholar
• Jeffries MA, Stern MA, Guamaratnum NT, Fontana RJ. Unsuspected infection is infrequent in asymptomatic out patients with refractory ascites undergoing therapeutic paracentesis. Am. J. Gastroenterol.94, 2972–2976 (1999).
   PubMed Web of Science ®Google Scholar
• Romney R, Mathurin P, Ganne-Carrie N et al. Usefulness of routine analysis of ascitic fluid at the time of therapeutic paracentesis in asymptomatic outpatients. Results of a multicenter prospective study. Gastroenterol. Clin. Biol.29(3), 275–279 (2005).
   PubMedGoogle Scholar
• Cholongitas E, Papatheodoridis GV, Lahanas A, Xanthaki A, Kontou-Kastellanou C, Archimandritis AJ. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int.25, 57–61 (2005).
   PubMed Web of Science ®Google Scholar
• Campillo B, Richardet J-P, Kheo T, Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin. Infect. Dis.35, 1–10 (2002).
   PubMed Web of Science ®Google Scholar
• Dupeyron C, Campillo B, Mangeney N, Richardet JP, Leluan G. Changes in nature and antibiotic resistance of bacteria causing peritonitis in cirrhotic patients over a 20 year period. J. Clin. Pathol.51(8), 614–616 (1998).
   PubMed Web of Science ®Google Scholar
• Paterson DL. “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin. Infect. Dis.38(4), S341–S345 (2004).
   PubMed Web of Science ®Google Scholar
• Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg. Infect. Dis.9(11), 1415–1422 (2003).
   PubMed Web of Science ®Google Scholar
• MacDougall C, Harpe SE, Powell JP, Johnson CK, Edmond MB, Polk RE. Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use. Emerg. Infect. Dis.11(8), 1197–1204 (2005).
   PubMed Web of Science ®Google Scholar
• Campillo B, Dupeyron C, Richardet JP, Mangeney N, Leluan G. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxatin. Clin. Infect. Dis.26(5), 1066–1070 (1998).
   PubMed Web of Science ®Google Scholar
• Campillo B, Dupeyron C, Richardet JP. Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol. Infect.127(3), 443–450 (2001).
   PubMed Web of Science ®Google Scholar
• Desai D, Desai N, Nightingale P, Elliott T, Neuberger J. Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation. Liver Transpl.9(7), 754–759 (2003).
   PubMed Web of Science ®Google Scholar
• Rimola A, Salmerón JM, Clemente G et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology21, 674–679 (1995).
   PubMed Web of Science ®Google Scholar
• Navasa M, Follo A, Llovet JM et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology111, 1011–1017 (1996).
   PubMed Web of Science ®Google Scholar
• Ricart E, Soriano G, Novella MT et al. Amoxicillin–clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J. Hepatol.32, 596–602 (2000).
   PubMed Web of Science ®Google Scholar
• Strauss E, Ribeiro MFGS. Bacterial infections associated with hepatic encephalopathy: prevalence and outcome. Ann. Hepatol.2(1), 41–45 (2003).
   PubMedGoogle Scholar
• Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J. Hepatol.32, 157–160 (2000).
   PubMed Web of Science ®Google Scholar
• Such J, Hilebrand DJ, Guarner C et al. Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis. Eur. J. Gastroenterol.16, 571–577 (2004).
   PubMed Web of Science ®Google Scholar
• Lopez-Talavera JG, Cadelina G, Olchowski J, Merril W, Groszmann R. Thalidomide inhibits tumor necrosis alpha, decreases nitric oxide synthesis and ameliorates the hyperdynamic circulatory syndrome in portal hypertensive rats. Hepatology23, 1616–1621 (1996).
   PubMed Web of Science ®Google Scholar
• Wiest S, Das G, Cadelina G, Miltien S, Garcia-Tsao G, Groszmann R. Bacterial translocation to limph nodes of cirrhotic rats stimulates e NOS-derived NO production and impairs mesenteric vascular contractility. J. Clin. Invest.104, 1223–1233 (1999).
   PubMed Web of Science ®Google Scholar
• Ruiz-del-Arbol L, Urmam J, Gonzalez M et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology38, 1210–1218 (2003).
   PubMed Web of Science ®Google Scholar
• Strauss S, Caly WR, Ribeiro MFG et al. Spontaneous bacterial peritonitis – predictive factors of non-response to I.V. cephalosporin (3rd generation) Hepatology34(4), 540A (2001).
   Google Scholar
• Pinzello G, Simonetti R, Camma C et al. Spontaneous bacterial peritonitis: an update. Gastroenterol. Int.6, 54–60 (1993).
   Google Scholar
• Grangé JD. Ascite-comment traiter une ascite? Gastroenterol. Clin. Biol.28, 8278–8286 (2004).
   Google Scholar
• Felisart J, Rimola A, Arroyo V et al. Cefotaxime is more effective than is ampicillin–tobramycin in cirrhotics with severe infections. Hepatology5, 457–462 (1985).
   PubMed Web of Science ®Google Scholar
• Runyon BA, Akriviadis EA, Sattler FR et al. Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for peritonial peritonitis. Dig. Dis. Sci.36(12), 1782–1786 (1991).
   PubMed Web of Science ®Google Scholar
• Runyon BA, McHutchison JC, Antillon MR, Akriviadis EA, Montano AA. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. Gastroenterology100, 1737–1742 (1991).
   PubMed Web of Science ®Google Scholar
• Grange JD, Amiot X, Grange V et al. Amoxicillin–clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients. Hepatology11, 360–364 (1990).
   PubMed Web of Science ®Google Scholar
• Gomez-Jimenez J, Ribera E, Gasser I et al. Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob. Agents Chemother.37(8), 1587–1592 (1993).
   PubMed Web of Science ®Google Scholar
• Mercader J, Gomez J, Ruiz J, Garre MC, Valdes M. Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients. Chemotherapy35(Suppl. 2), 23–26 (1989).
   PubMedGoogle Scholar
• Rimola A, Titó L, Llach J et al. Efficacy of ceftizoxime in the treatment of severe bacterial infections in patients with cirrhosis. Drug Invest.4(Suppl. 1), 35–37 (1992).
   Google Scholar
• Silvain C, Breux JP, Grollier G et al. Les septicemias et les infections du liquide d’ascite du cirrhotique peuvent-elles étre traitées exclusivement par voie orale? Gastroenterol. Clin. Biol.13, 335–339 (1989).
   PubMedGoogle Scholar
• Terg R, Cobas S, Fassio E et al. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J. Hepatol.33, 564–569 (2000).
   PubMed Web of Science ®Google Scholar
• Follo A, Llovet JM, Navasa M et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology20, 1495–1501 (1994).
   PubMed Web of Science ®Google Scholar
• Navasa M, Follo A, Filella X et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis: relationship with the development of renal impairment and mortality. Hepatology20, 819–824 (1998).
   Google Scholar
• Ginés P, Guevara M, de las Heras D, Arroyo V. Review article: albumin for circulatory support in patients with cirrhosis. Aliment. Pharmacol. Ther.16(Suppl. 5), 24–31 (2002).
   PubMed Web of Science ®Google Scholar
• Sort P, Navasa M, Arroyo V et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N. Engl. J. Med.341, 403–409 (1999).
   PubMed Web of Science ®Google Scholar
• Navasa M, Rodes J. Bacterial infections in cirrhosis. Liver Int.24, 277–280 (2004).
   PubMed Web of Science ®Google Scholar
• Shalit I. Immunological aspects of new quinolonas. Eur. J. Microbiol. Infect. Dis.10, 262–266 (1991).
   PubMed Web of Science ®Google Scholar
• Rimola A, Bory F, Terés J, Pérez-Ayuso RM, Arroyo V, Rodés J. Oral non-absorbable antibiotics prevent infection in cirrhosis with gastrointestinal hemorrhage. Hepatology5, 463–467 (1985).
   PubMed Web of Science ®Google Scholar
• Soriano G, Guarner C, Tomas A et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology103, 1267–1272 (1992).
   PubMed Web of Science ®Google Scholar
• Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology29, 1655–1661 (1999).
   PubMed Web of Science ®Google Scholar
• Novella M, Sola R, Soriano G et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology25, 532–536 (1997).
   PubMed Web of Science ®Google Scholar
• Grange JD, Roulot D, Pelletier G et al. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites – a double blind randomized trial. J. Hepatol.29, 430–436 (1998).
   PubMed Web of Science ®Google Scholar
• Soriano G, Guarner C, Teixido M et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology100(2), 477–481 (1991).
   PubMed Web of Science ®Google Scholar
• Gines P, Rimola A, Planas R, Vergas V, Marco F, Almeida M. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a doublé-blind, placebo-controlled trial. Hepatology12, 716–724 (1990).
   PubMed Web of Science ®Google Scholar
• Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis. Digestion59, 54–57 (1998).
   PubMed Web of Science ®Google Scholar
• Younossi ZM, McHutchinson JG, Gamiats TG. An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis. J. Hepatol.27, 295–298 (1997).
   PubMed Web of Science ®Google Scholar
• Pardo A, Bartoli R, Lorenzo Zuñiga V et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology31, 858–863 (2000).
   PubMed Web of Science ®Google Scholar
• Bauer TM, Fernanadez J, Navasa M et al. Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis. J. Hepatol.36, 501–506 (2002).
   PubMed Web of Science ®Google Scholar